About
Brings over 25 years of pharmaceutical R&D and regulatory experience, having been a pre-clinical pharmacology expert on drugs including Wellbutrin SR and Zyban. He previously co-founded life science companies and served as president/CEO of Cytospect, Cytoscan and Neurotherapeutics, and holds a PhD from London University and an MBA from Duke.